Rigel Pharmaceuticals Inc. (New)

RIGLNASDAQ • USD
42.61 USD
↘ 1.12 (2.56%)🟢LIVE (AS OF 02:25 PM EST)
🟢Market: OPEN

Rigel Pharmaceuticals Inc. (New) (RIGL) is currently trading at $42.61. Technicals currently rate "Sell" while our fundamental analysis reads "Neutral". Notable factors include a robust Altman Z-Score, exceptional Return on Equity (69.0%) and a bullish Golden Cross on the moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Nov 16, 2026.

Open?$43.43
High?$43.71
Low?$41.88
Prev. Close?$43.73
Volume?113.4K
Avg. Volume?236.3K
VWAP?$42.61
Rel. Volume?0.48x
Bid / Ask
Bid?$36.94 × 100
Ask?$49.00 × 100
Spread?$12.06
Midpoint?$42.97
Valuation & Ratios
Market Cap?823.4M
Shares Out?18.8M
Float?16.7M
Float %?89.5%
P/E Ratio?2.68
P/B Ratio?1.85
EPS?$16.31
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, REZLIDHIA (olutasidenib), GAVRETO (pralsetinib), R289, and Ocadusertib (Systemic) - Eli Lilly.
Employees
174
Market Cap
823.4M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2000-11-29
Address
611 GATEWAY BOULEVARD, SUITE 900
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-624-1100
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
98
Momentum?
33
Short Sent.?
44
Piotroski F-Score?3/9Weak
Altman Z-Score?4.92Safe
Confidence?53%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?15.16%High
Short Interest?2.5M
Days to Cover?12.9
Free Float16.7M
Avg Daily Volume196.1K
Settlement Date2026-10-30
Financial Health
Current Ratio?2.39Strong
Quick Ratio?2.19Strong
Cash Ratio?0.59Adequate
Debt/Equity?0.02Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
Peers
100
S&P
97
2.7CHEAP▾
P/B?
Peers
100
S&P
78
1.85CHEAP▾
P/S?
Peers
100
S&P
52
2.86CHEAP▾
P/FCF?
Peers
100
S&P
91
9.2CHEAP▾
EV/EBITDA?
Peers
100
S&P
82
9.9CHEAP▾
EV/Sales?
Peers
100
S&P
65
2.72CHEAP▾
Returns & Efficiency
ROE?
Peers
50
S&P
94
69.0%STRONG▾
ROA?
Peers
50
S&P
97
58.6%STRONG▾
Cash Flow & Enterprise
FCF?$89.9M
Enterprise Value?$784.0M
Fundamentals ratios updated end of day